Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 622-634

  Eberhardt, W ^a   Wilke, H ^a   Stamatis, G ^a   Stuschke, M ^a   Harstrick, A ^a   Menker, H ^a   Krause, B ^a   Mueller M R ^a   Stahl, M ^a   Flasshove, M ^a   Budach, V ^a   Greschuchna, D ^a   Konietzko, N ^a   Sack, H ^a   Seeber, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZAPRIDE; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CERVICAL LYMPH NODE; ESOPHAGITIS; FEMALE; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PLEURA EMPYEMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA;

EID: 0031892210     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.622     Document Type: Article

References (50)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. Ca 47:5-27, 1997
2. Mountain CF: A new international staging system for lung cancer. Chest 89:225S-233S, 1986 (suppl 4)
3. Ginsberg RJ, Kris MG, Armstrong JG: Cancer of the lung, section 1: Non-small cell lung cancer, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 673-723
4. Perez CA, Pajak TF, Rubin P, et al: Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59:1874-1881, 1987
5. Hazuka MB, Bunn PA Jr: Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Am Rev Respir Dis 145:967-977, 1992
6. Shepherd FA: Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 55:1585-1592, 1993
7. Johnson DH, Turrisi AT, Pass HJ: Combined modality treatment for locally advanced non-small cell lung cancer, in Pass HJ, Mitchell J, Johnson DH, et al (eds): Lung Cancer: Principles and Practice. Philadelphia, PA, Lippincott-Raven, 1996, pp 863-873
8. Dillman RO, Seagren SL, Propert K, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940-945, 1990
9. Dillman RO, Seagren SL, Herndon J, et al: Randomized trial of induction chemotherapy plus radiation therapy vs. RT alone in stage III non-small cell lung cancer: Five year follow-up of CALGB 84-33. Proc Am Soc Clin Oncol 12:329, 1993 (abstr 1092)
10. Le Chevalier T, Arriagada R, Tarayre M, et al: Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84:58, 1992
11. Thames HD, Bentzen SM, Turesson I, et al: Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 19:219-235, 1990
12. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934. 1990
13. Turrisi AT III, Glover DJ, Mason BA: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 15:183-187, 1988
14. Shaw EG, McGinnis WL, Jett JR, et al: Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small cell carcinoma of the lung. J Natl Cancer Inst 85:321-323, 1993
15. Goldie JH, Coldman AJ: The genetic origin of drug resistance in neoplasms: Implications for systemic therapy. Cancer Res 44:3643-3653, 1984
16. DeVita VT Jr: The James Ewing lecture: The relationship between tumor mass and resistance to chemotherapy - Implications for surgical adjuvant treatment of cancer. Cancer 51:1209-1220, 1983
17. Feld R, Rubinstein L, Thomas P, et al: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. J Natl Cancer Inst 85:299-306, 1993
18. Maassen W, Greschuchna D, Kaiser D, et al: Empfehlungen zur Diagnostik, Stadieneinteilung und operativen Therapie des Bronchialkarzinoms. Thorac Cardiovasc Surg 36:295-306, 1988
19. Wilke H, Achterrath W, Schmoll HJ, et al: Etoposide and split-dose cisplatin in small cell lung cancer. Am J Clin Oncol 11:572-578, 1988
20. Sause WT: Prophylactic cranial irradiation: Advantages and disadvantages. Ann Oncol 3:S51-S55, 1992 (suppl 3)
21. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
22. Green MR, Cox JD, Ardizzoni A, et al: Endpoints for multimodal clinical trials in stage III non-small cell lung cancer: A consensus report. Lung Cancer 11:S11-S13, 1994 (suppl 3)
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
25. Cox DR, Oakes D: Analysis of Survival Data. London, United Kingdom, Chapman & Hall, 1984
26. Sause WT, Turrisi AT: Principles and application of preoperative and standard radiotherapy for regionally advanced non-small cell lung cancer, in Pass HJ, Mitchell J, Johnson DH, et al (eds): Lung Cancer: Principles and Practice. Philadelphia, PA, Lippincott-Raven, 1996, pp 697-710
27. Weiden PL, Piantadosi S, for the Lung Cancer Study Group: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: A phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 83:266-273, 1991
28. Strauss GM, Herndon JE, Sherman DD, et al: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung : Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237-1244, 1992
29. Palazzi M, Cataldo I, Gramaglia A, et al: Preoperative concomitant cisplatin and radiotherapy in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:621-625, 1993
30. Deutsch M, Crawford J, Leopold K, et al: Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74:1243-1252, 1994
31. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880-1892, 1995
32. Favaretto A, Paccagnella A, Tomio L, et al: Preoperative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study. Eur J Cancer 32A:2064-2069, 1996
33. Choi NC, Carey RW, Daly W, et al: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15:712-722, 1997
34. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205, 1995a
35. Sause WT, Scott C, Taylor S, et al: RTOG 88-08 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable non-small-cell lung cancer with minimum three year follow-up. Int J Radiat Oncol Biol Phys 32:195, 1995b (suppl 1)
36. Taylor MA, Reddy S, Lee MS, et al: Combined modality treatment using BID radiation for locally advanced non-small cell lung carcinoma. Cancer 73:2599-2606, 1994
37. Jeremic B, Jevremovic S, Mijatovic L, et al: Hyperfractionated radiation therapy with or without concurrent chemotherapy for advanced non-small cell lung cancer. Cancer 71:3732-3736, 1993
38. Van Raemdonck DE, Schneider A, Ginsberg RJ: Surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg 54:999-1013, 1992
39. Fowler WC, Langer CJ, Curran WJ, et al: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55:986-989, 1993
40. Rusch VW, Benfield JR: Neoadjuvant therapy for lung cancer: A note of caution. Ann Thorac Surg 55:820-821, 1993
41. O'Connell JP, Kris MG, Gralla RJ, et al: Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol 4:1604-1614, 1986
42. Osterlind K, Andersen PK : Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189-4194, 1986
43. Arriagada R, Kramar A, Le Chevalier T, et al: Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol 10:447-451, 1992
44. Kawahara M, Furuse K, Kamimori T, et al: Risk of second primary tumor in > 2 year disease-free survivors of small cell lung cancer in Japan. Proc Am Soc Clin Oncol 14:353, 1995 (abstr 1070)
45. Quoix E, Moro D, Jacoulet P, et al: Long-term survivors in non-resected non-small cell lung cancer patients: A French data base. Proc Am Soc Clin Oncol 14:368, 1995 (abstr 1130)
46. Pisters KMW, Kris MG, Gralla RJ, et al: Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 11:1757-1762, 1993
47. Arriagada R, Le Chevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87:183-190, 1995
48. Elias AD, Skarin AT, Gonin R, et al: Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results. Am J Clin Oncol 17:26-36, 1994
49. Tishler RB, Schiff PB, Geard CR, et al: Taxol: A novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22:613-617, 1992
50. Saunders EG, Mc Ginnis WL, Jett JR, et al: Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer. Lung Cancer 9:221-224, 1993